Orrick Herrington & Sutcliffe LLP advised Quit Genius in the transaction.
Quit Genius, a developer of personalized digital therapeutics for addictions, on its $11 million Series A financing round. The round was led by Octopus Ventures, with other investors in the round including Y Combinator, Startup Health, Triple Point Ventures, Serena Ventures and Venus Williams, amongst others. Other existing investors in the company include Eric Ries and Instacart co-founder Max Mullen.
Quit Genius develops personalized digital therapeutic for addictions, using programmatically-delivered cognitive behavioral therapy, expert coaching, a connected breath sensor and easy access to proven medication. The company was founded by three doctors — Yusuf Sherwani (CEO), Maroof Ahmed (COO) and Sarim Siddiqui (Head of Product) – who met in medical school. The company intends to use the new funds to expand its therapeutic programs beyond cigarette and vaping addiction to include alcohol and substance abuse, as well as increase its presence in the U.S., which is currently experiencing an opioid ‘epidemic’.
The Orrick team included John Bautista (Picture), Chris Grew, John Harrison, Jason Wu, Jonathan Rosen, Jeanine McGuinness, Natasha Ahmed, Laura Haworth, Beth Kruszynskyj and Henry Yen.
Involved fees earner: Natasha Ahmed – Orrick; John Bautista – Orrick; Christopher Grew – Orrick; John Harrison – Orrick; Laura Haworth – Orrick; Jeanine McGuinness – Orrick; Jonathan Rosen – Orrick; Jason Wu – Orrick;
Law Firms: Orrick;
Clients: Quit Genius;